ABSTRACT: Monocyte-derived macrophage (M⌽) subsets are generated by antagonistic induction pathways. A helper M⌽-type (Mh-M⌽) is induced by interferon gamma (IFN-␥), whereas a cytotoxic M⌽-type (Mc-M⌽), induced by interleukin-10 (IL-10), is a potent mediator of antibody-dependent cellular cytotoxicity (ADCC). Compared with M⌽ from healthy adults [peripheral blood monocyte-derived macrophages (PBM⌽)], cord blood M⌽ (CBM⌽) were found less capable of generating Mh-M⌽. Here we tested the hypothesis that their generation of Mc-M⌽ via IL-10 is also impaired. M⌽ surface markers were phenotyped. IL-10 protein and mRNA production were detected after stimulation [␣CD3 monoclonal antibody (mAb)]. CBM⌽ or PBM⌽ were co-cultured with M⌽-depleted mononuclear cells of adults and CD4-targeting antibodies as models for ADCC were added. In cord blood, we found diminished ␣CD3-induced IL-10 protein and mRNA production (p Ͻ 0.05 versus adults). Basal CD16 and HLA-DR expressions on CBM⌽ of preterm and full-term neonates were lower (p Ͻ 0.05 versus PBM⌽). IL-10 had reduced effects on CD16 up-and HLA-DR down-modulation on CBM⌽ (p Ͻ 0.05 versus PBM⌽). CD4-directed receptor modulation and deletion were reduced in the presence of CBM⌽ (p Ͻ 0.05 versus PBM⌽). IL-10 failed to enhance their ADCC capacity, which was in contrast to PBM⌽ (p Ͻ 0.05). These data suggest that CBM⌽ have an impaired cytotoxic capacity via lower sensitivity toward IL-10. (Pediatr Res 60: 152-157, 2006) 
Q ualitative characteristics of immune responses are regulated by immune cell subsets through their production of distinct cytokines. TH1 cytokines, e.g. IFN-␥, play an important role in the inflammatory response and promote cell-mediated responses against bacteria, whereas TH2 cytokines, e.g. IL-10, induce antibody synthesis and promote immunoregulatory signals. Evidence exists that the neonatal period is characterized by a TH2-dominated immune response with a hyporesponsive inflammatory component (1, 2) . In contrast, clinical observation reveals a more severe parainfectious systemic inflammatory response in neonates than in children and adults, often with detrimental sequelae (3) . Consistent with these findings, neonates show an enhanced capacity to produce proinflammatory cytokines during infections (4) and inflammatory diseases, e.g. bronchopulmonary dysplasia (5) or periventricular leukomalacia (6) .
Cytokines orchestrate T cell immune responses either directly or indirectly via antigen presenting cells, e.g. blood monocytes or M⌽. Via antagonistic cytokine induction pathways, at least two M⌽ subsets, displaying distinct phenotypes and functions, have been distinguished (7): IFN-␥ generates a costimulatory helper M⌽-type (Mh) which expresses and up-regulates B7 family receptors (CD80, B7-1 and CD86, B7-2) (8) . Its engagement of T cell CD28 family molecules influences T cell survival, activation, and TH1/TH2 cytokine production [for review, see Salomon and Bluestone (9) ]. In contrast, IL-10 not only mediates inhibitory and immunoregulatory signals, but induces a cytotoxic M⌽-type (Mc) (8) , which fails to up-regulate HLA-DR and B7 molecules. Mc-M⌽ instead express Fc-gamma III receptors (CD16) in high density (7) . Mc-M⌽ are potent mediators that destroy antibody-coated, e.g. virus-infected, cells by ADCC via induction of apoptosis (10) .
We found CBM⌽ less capable of generating Mh-M⌽ due to diminished IFN-␥ effects on B7 molecules, thereby inhibiting M⌽-dependent T cell activation (11, 12) . Here, we tested the hypothesis that their generation of Mc-M⌽ via IL-10 in cord blood is also impaired.
MATERIALS AND METHODS
Patients. The study protocol was approved by the Ethics Committee of the University of Tuebingen. All mothers had given written consent before they went into labor. Randomly selected, adult healthy donors served as controls.
All term neonates were delivered spontaneously and did not exhibit signs of infection, as defined by the clinical status, and, if necessary, C-reactive protein. Ten preterm neonates (medium gestational age 29.5 wk; range, 25.5-32.6 wk; medium birth weight, 1350 g; range, 650 -1690 g) were delivered for maternal reasons [cervix insufficiency (n ϭ 5), preeclampsia (n ϭ 4), or placental ablation (n ϭ 1)]. Maternal antibiotics and antenatal steroids (up to 4 wk before labor) were given to seven of 10 preterm neonates, four infants were from multiparous pregnancies. Although six preterm infants were treated with antibiotics, none developed serological or clinical signs of early-onset bacterial infection. Mothers with amnion infections or prolonged labor were excluded. Umbilical cord blood was drawn by puncture with a sterile needle and placed in heparin-coated tubes (100 IE/mL blood) immediately following cord ligation.
Cell cultures. Peripheral blood and cord blood mononuclear cells (PBMNCs and CBMNCs) were isolated by density gradient centrifugation (Biochrom AG, Berlin, Germany). Washed cells were resuspended in VLE RPMI 1640 (Biochrom), containing 10% FCS (Biochrom). Cells were counted in an ultraplane Neubauer hemocytometer, placed at 2 ϫ 10 6 cells/mL in flat-bottom, 24-well cell culture plates (Costar, Bodenheim, Germany) and incubated at 37°C.
Preparation of mononuclear cell subsets. To separate M⌽ from lymphocytes, cells were plated at 3 ϫ 10 6 cells per 1.5 mL in 60 ϫ 15-mm culture vessels (NoK4-3802-4, BD Biosciences, Heidelberg, Germany) in the incubator and allowed to adhere for 60 min. Nonadherent cells were gently removed by repeatedly pipetting 500 L of RPMI buffer into the cultures. Remaining adherent cells were twice thoroughly washed and used as a source of M⌽. Usually, 95% of adherent cells were viable and 85% expressed CD14.
Remaining CD14
Ϫ cells were negative for the natural killer cell receptor CD56. To further eliminate contaminating nonadherent M⌽, the procedure described above was repeated with the nonadherent cell fraction. Usually, Ͻ1% CD14 ϩ M⌽ were found in the nonadherent fraction after this adherence cycle, as determined by fluorescence-activated cell sorter analysis.
Co-culture experiments. M⌽-enriched adherent cells (1 ϫ10 6 /0.5 mL) and M⌽-depleted nonadherent cells (2 ϫ 10 6 /0.5 mL) were mixed. Nonadherent cell fractions were not pooled from different donors. To equalize allogeneic effects, CBM⌽ and PBM⌽ of one adult donor were cocultured with nonadherent, nonirradiated cells of a second adult donor. In none of the coculture experiments did we see any significant T cell deletion in the absence of deleting reagents, as observed earlier (10) . Anti-CD3-mediated T cell proliferation required the presence of M⌽ or the addition of a co-mitogenic anti-CD28 mAb (L293 low azide, 1 g/mL, BD Biosciences,) and was assessed by Vybrant CFDA SE Cell Tracer Kit (Molecular Probes, Eugene, OR) according to the manufacturer's protocol.
IL-10 quantification by electroimmunoassay. IL-10 was quantified in supernatants using human IL-10 OptEIA (BD-PharMingen, Freiburg, Germany) according to the manufacturer's instructions. The OD was measured photometrically at 450 nm in an enzyme-linked immunosorbent assay reader Spectra (Tecan, Frankfurt, Germany). Samples were analyzed in duplicate and blotted against a standard curve (Mathcad Professional 2000). The assay detected values as low as 7.8 pg/mL. Flow cytometry. A FACScan flow cytometer (BD Biosciences) was used. To prevent nonspecific binding, cells were incubated with 10% human serum on ice for 10 min before staining with fluorescein-isothiocyanate-, phycoerythrin-, or isotype-specific immunoglobulin-labeled mAb for 20 min in the dark. M⌽ were gated by forward scatter, side scatter, and CD14 expression. Dead lymphocytes were discriminated by propidium iodide (PI) (Molecular Probes, 5 g/mL, 5 min). PI-negative cells were counted, double stained for CD4/CD3 and CD8/CD3, and analyzed for expression of CD4 and CD8. The percentage of deleted T cells was determined as previously described (13) applying the formula: percentage of deleted T cells ϭ 1 Ϫ remaining T cells ϭ 1 Ϫ (T cells cultured with deleting reagent at day 2: T cells cultured without deleting reagent at day 2) ϫ 100. mRNA quantification. For RNA extraction, the MagNA Pure LC RNA Isolation Kit I (Roche, Mannheim) was used as described previously (14) . Synthesis of cDNA was performed using the First Strand cDNA Synthesis Kit (Roche). Amplification and quantification of cDNA were performed using a standard LightCycler protocol and external standardization, based on fluorescence resonance energy transfer (FRET) with specific oligonucleotides (14) . External standards consisting of purified polymerase chain reaction products were quantified by spectral photometry, followed by serial dilution to obtain defined amounts of input copy numbers. All results were normalized against the expression of the housekeeping gene ALAS (5-aminolevulinate synthase gene)
Reagents. To target CD4 T cells that we used a chimeric humanized antibody (anti-CD4 mAb, ␣CD4; ch 412, 1 g/mL; gift from Gerd Riethmuller, Munich, Germany) and immune complexes, consisting of recombinant HIV-1 gp120SF2 (1 g/mL, kindly provided by K. Steimer, Chiron Biocine, Emeryville, CA) and serum from an HIV seropositive donor (New York Medical College, Valhalla, NY; final dilution 1:1000) as source of anti-gp120 (␣gp120) antibody as previously described (15) . The T cell mitogen anti-CD3 (␣CD3 mAb; OKT3, 5 g/mL) was used as a soluble antibody and purchased from Ortho Diagnostics (Raritan, NJ). Antibodies to CD14 (M⌽P9), CD80 (L307.4), HLA-DR (L243), CD3 (SK7), CD56 (NCAM16.2), CD8 (SK1), CD28 (L293), and immunoglobulin (Ig)-matched controls (IgG1, IgG2b) were purchased from BD Biosciences. Remaining CD4 T cells were detected by OKT4 (Ortho), which is a non-cross reactive antibody to ch412 (10) .
Data display and statistical analysis. Fluorescence intensities were determined and the nonspecific background staining was subtracted. Results are expressed as mean Ϯ SD. Statistical analysis was performed by using the decadic logarithm of the values of CD16, HLA-DR, and CD80. Using analysis of variance, it was examined whether the variables were influenced by IL-10 or age (both nominal effects). Using an analysis of covariance, it was examined whether the decadic logarithm of numbers of remaining T cells were influenced by time or the origin of the blood. The variable "patient" was nested and modeled as a random effect; an interaction between "patient" and "day" was considered. Values of p Ͻ 0.05 were considered statistically significant. Statistical analysis was performed using the Sigmaplot 2000 software for Windows (SPSS, Chicago, IL).
RESULTS

IL-10 production after stimulation with a T cell mitogen.
To compare IL-10 production in mononuclear cells of cord blood and peripheral blood of adults (CBMNCs and PBMNCs), we used an in vitro stimulation with ␣CD3 mAb (Fig. 1 ). Supernatants were analyzed at 6, 12, 24, and 48 h. Unstimulated mononuclear cells produced low IL-10 concentrations after 48 h. We found a substantial increase in IL-10 protein production in PBMNCs, which was in contrast to CBMNCs (p Ͻ 0.05; Fig. 1A ) and also evident at the mRNA transcriptional level after 24 h (Fig. 1B) . In the presence of M⌽ (Fig. 1 C) , the addition of a co-mitogen (anti-CD28 mAb, ␣CD28 mAb) to ␣CD3 mAb markedly enhanced T cell proliferation in PBMNCs and CBMNs (not shown), but induced only little IL-10 production in CBMNCs after 48 h (Fig. 1 C) . In the absence of M⌽ (Fig. 1D) , IL-10 production of PBMNCs was lower in the stimulated groups (p Ͻ 0.05 versus corresponding groups with M⌽).
IL-10-mediated effects on CD16 and HLA-DR expression on M⌽. To analyze IL-10-mediated effects on M⌽ phenotypes, CD16 and HLA-DR expression on CBM⌽ of preterm and full-term neonates, as well as on PBM⌽, were assessed after stimulation for 48 h (Fig. 2) . Basal receptor expressions were reduced on CBM⌽ (p Ͻ 0.05 versus PBM⌽), with lower densities on preterm neonates (p Ͻ 0.05 versus full-term neonates). IL-10 up-regulated CD16 dose dependently on PBM⌽ (p Ͻ 0.05 versus unstimulated PBM⌽), but only slightly on CBM⌽ (p Ͼ 0.05; Fig. 2A ). IL-10-induced HLA-DR down-modulation on PBM⌽ was dose dependent as well and more pronounced (p Ͻ 0.05 versus unstimulated PBM⌽), whereas this effect was only marginal on CBM⌽ (p Ͼ 0.05 versus unstimulated CBM⌽; Fig. 2B ). For both parameters, IL-10-mediated effects were not different between CBM⌽ of term and preterm neonates (p Ͼ 0.05). M⌽ survival did not differ between groups, but in the presence of IL-10, M⌽ cell death increased from 15% to 26% (500 ng/mL IL-10) after 48 h (not shown).
M⌽-mediated CD4-directed T cell deletion. As shown previously, IL-10 enhances cytotoxic M⌽ function by facilitating T cell deletion via ADCC (7,10). Before analyzing this 153 function, we assessed the basal ADCC capacity of PBM⌽ and CBM⌽, directed against CD4 T cells. M⌽-depleted PBMNC of one adult donor were incubated either with CBM⌽ or PBM⌽ of a second unrelated adult donor. We chose this system to avoid a potentially different sensitivity toward ADCC-mediated apoptosis between neonatal and adult T cells. M⌽ were added in different concentrations in the absence or presence of a CD4 T cell-directed deleting antibody (␣CD4 mAb) for 48 h (Fig. 3 ). CD4 T cell deletion was dependent on the presence of M⌽ and their concentrations added. Although both CBM⌽ and PBM⌽ induced CD4 T cell deletion (p Ͻ 0.05 versus ␣CD4-treated M⌽-depleted PBMNCs), it was stronger in the presence of PBM⌽ in all M⌽: lymphocyte ratios (p Ͻ 0.05 versus CBM⌽, Fig. 3A) . The deletion was specific for CD4 T cells; CD8 T cells remained unaffected (Fig. 3B) .
CD4 T cell apoptosis-preceding events were shown to be CD4 receptor down-modulation and co-modulation of other surface receptors e.g. CD3 and CD28 (8) . These phenomena were found on the remaining CD4 T cells with both M⌽ subsets (Fig. 4) . In the presence of PBM⌽ versus CBM⌽, CD4 down-modulation was 63 versus 25%, CD3 comodulation was 35 versus 13%, and CD28 co-modulation 40% versus 66% (Table 1 , all p Ͻ 0.05). Neither downmodulation nor deletion occurred in the absence of ␣CD4mAb (not shown).
Effect of IL-10 on enhancement of M⌽ cytotoxicity. To compare IL-10 cytotoxicity, M⌽-depleted PBMNCs of one adult donor were cocultured either with CBM⌽ or PBM⌽ of 154 a second unrelated adult donor for 48 h as described above. Targets again were CD4 T cells, forming M⌽ conjugates either by ␣CD4 mAb or immune complexes, consisting of immune-complexed HIV-envelope protein gp120. IL-10 was added to both groups (Fig. 5) . Again, CBM⌽ and PBM⌽ induced T cell deletion via antibody and immune complexes (p Ͻ 0.05 versus corresponding groups without deleting substances, not shown). PBM⌽ were more effective though in eliminating CD4 T cells by both, ␣CD4 mAb and immune complexes (p Ͻ 0.05 versus CBM⌽; first versus third column). Addition of IL-10 increased M⌽ cytotoxicity in cultures with PBM⌽ (p Ͻ 0.05 versus deleting substance only), which was in contrast to CBM⌽ (p Ͼ 0.05). IL-10 (50 ng/mL) did not affect CD4 or M⌽ survival (not shown).
DISCUSSION
The scope of our experiments was to determine the production of IL-10 and its influence on phenotype and cytotoxic function of CBM⌽ versus PBM⌽. We first found a diminished IL-10 protein and mRNA production in dCD3-stimulated CBMNCs (Fig. 1) . Second, the basal CD16 and HLA-DR expression on, and the cytotoxic capacity mediated by CBM⌽ were reduced (Figs. 2-4) . Third, IL-10-mediated effects on CBM⌽ phenotype (Fig. 2) and their cytotoxic function (Figs. 4 and 5, Table 1 ), were impaired. Taken together, our data suggest CBMNCs to produce less IL-10 and CBM⌽ to be less sensitive toward IL-10 and less capable of generating Mc-M⌽ in our experimental setup. These results are consistent with recent work suggesting that the neonatal immune response is not only deficient in promoting activation (11) but also inhibition (4, 5) .
IL-10 is produced by various cells, including monocytes, M⌽, and T cells. Although neonates are capable of producing considerable amounts of IL-6 and IL-10 when induced via endotoxins, e.g. during sepsis (16, 17) , results of neonatal IL-10 production are conflicting and depend on the stimulation used (17) (18) (19) . We found a profoundly diminished IL-10 mRNA and protein production in CBMNCs stimulated with anti-CD3 (Fig. 1) . Anti-CD3-stimulated neonatal T cells already were shown to produce significantly less IL-10 than T cells from adults (18) . A more detailed characterization of IL-10 production by naïve (CD45RA) versus memory (CD45RO) CD4 T cells revealed the latter subset to produce significantly more IL-10 (18). This subset is virtually absent in healthy neonates and may partly explain the reduced IL-10 73 (14) 25 (12) 91 (14) 55 (10)* M⌽-depleted PBMNCs (2 ϫ 10 6 ) were cocultured with 1 ϫ 10 6 PBM⌽ from a second adult donor or CBM⌽ in the presence or absence of ␣CD4 mAb (1 g/mL). CD4, CD3, and CD28 expression on CD4 T cells was assessed after 48 h. Three experiments are shown (mean Ϯ SD). *p Ͻ 0.05 vs ␣CD4 mAb-treated group with PBM⌽. No differences were seen on CD4 Ϫ cells (not shown). PBM⌽ (open columns) from a second adult donor or CBM⌽ (full-term neonate, solid columns) in the absence or presence of ␣CD4 (1 g/mL), or gp120/␣gp120 immune complexes and IL-10 (50 ng/mL) for 48 h. Remaining T cells were counted and phenotyped (n ϭ 4). No changes in the CD8 T cell fraction were seen (not shown); *p Ͻ 0.05 PBM⌽ vs CBM⌽, §p Ͻ 0.05 IL-10 ϩ ␣CD4 or gp120/␣gp120 (gp120ic) vs ␣CD4 or gp120/␣gp120. 155 production in CBMNCs (Fig. 1A-C) , most prominent in the absence of M⌽ (Fig. 1D) . Moreover, IL-10 production of naïve neonatal CD45RA T cells (18) and monocytes (19) were found to be reduced in similar experimental settings as well as after stimulation with endotoxin (4, 19) . Although the addition of a co-mitogen (anti-CD28 mAb) increased T cell proliferation in the presence of M⌽ (not shown), we did not find a significant increase in IL-10 production compared with anti-CD3 only (Fig. 1C) , which may be due to a relatively high mitogen concentration (5 g/mL).
CD16 and HLA-DR expression on CBM⌽ were lower in preterm than in full-term neonates (Fig. 2) , confirming earlier reports (12, 20, 21) . Conflicting phenotypic results showing equivalent or even increased CD16 expression on M⌽ from preterm neonates (22) may be related to maternal steroids or other medication. Glucocorticoids were shown to selectively deplete CD16 ϩ monocytes in adults (23) . Because antenatal steroids were administered to 70% of our preterm infants (Fig. 2) , further analysis on their influence on M⌽ survival is required. CD16
ϩ M⌽ represent a differentiated M⌽ subset that does not produce IL-10 (24,25) but strongly induces ADCC via CD95L and CD16 (26) . CD16
ϩ M⌽ increase in neonatal sepsis (27) and are involved in parainfectious tissue destruction in adults (28) . Taking the vulnerability of neonatal tissues into account, the reduced M⌽ CD16 expression and induction in preterm neonates may be of advantage in vivo.
To our knowledge, neonatal and adult M⌽-mediated ADCC, analyzed by flow cytometry on a single-cell basis ( 51 Cr release revealed diminished cytotoxicity of CBM⌽ toward chicken erythrocytes when conjugates were formed by heteroantibodies via Fcgamma I receptors (CD64) (29) . Our ADCC model targets CD4 T cells and involves Fc-gamma III (CD16) because ADCC is blocked by CD16 receptor blockade (15) . CD4 T cell receptor densities declined after conjugate formation with CD4-specific antibodies (Fig. 4, Table 1 ), confirming earlier reports (30) . Co-modulation of surface receptors is a preceding event of T cell apoptosis (31) and involves the CD95/CD95L system (10). Because M⌽ express and secrete CD95L (32) and IL-10 is capable of up-regulating CD95L (33) , it is conceivable that neonatal M⌽ do not primarily destroy lymphocytes that exhibit (auto)antibodies on their surface, but may form conjugates with nonlymphoid antibody-reactive tissues and induce apoptosis (34) . Increased CD95L concentrations were found in healthy neonates (35) and maternal or neonatal inflammatory diseases (36) . Therefore, a reduced CBM⌽ cytotoxicity could be a means to counterbalance apoptotic hyperreactions.
It is conceivable that our results are influenced by cells in the nonadherent fraction, which may have secondary effects on M⌽, or by the purification process via adherence. The latter may preactivate more mature monocytes and, although negative for natural killer cells, also select nonmonocytic cells. However, when we negatively selected M⌽ by magnetic bead depletion, the differences in ADCC capacity between CBM⌽ and PBM⌽ remained, suggesting the role of the CD14 negative cells in the M⌽-enriched environment to be of minor impact.
IL-10 was found to promote only minimal effects on neonatal T cells with respect to induction of B-cell helper functions compared with adults (18) . Its inhibitory effect on proinflammatory cytokine production was shown to be lower in preterm infants than in adults, indicating a reduced IL-10 response (4). Our data suggest CBM⌽ to be less sensitive toward IL-10 with respect to CD16 up-and HLA-DR downregulation (Fig. 2) , although this may be balanced by the genuinely lower receptor densities in vivo. In contrast to PBM⌽, we found no IL-10-mediated ADCC enhancement on CBM⌽ (Fig. 5) . Whether these findings are due to lower IL10 receptor densities, which are crucial in IL-10 signaling (37), compromised IL-10 binding properties to the receptor, and/or altered intracellular signal transduction in CBM⌽ has to be elucidated.
With respect to IL-10-mediated effects, our data should be interpreted with caution. We used an in vitro system with relatively small sample sizes. In addition, for reasons of sample volumes required, we have not yet longitudinally investigated kinetics of cord and peripheral blood of newborns. Our model may therefore not properly reflect the neonatal situation several days postnatally. This was a heterogeneous group of preterm neonates, and although none of them developed early-onset infection, we cannot rule out effects of multiparous pregnancy or maternal antibiotics or antenatal steroids on their immunologic profile. To examine these parameters, as well as interindividual variations, further experiments elucidating pathophysiological mechanisms are required.
In conclusion, our results provide further evidence that the neonatal immune response is not dominated by either pro-or anti-inflammatory reaction patterns but that the plasticity of both sides is restricted compared with adults. As a consequence, a diminished stability and following hyperreactions to both sides are to be expected.
